STEREOTAXIS, INC.
ST LOUIS, MO

Stereotaxis, Inc. is a company based in St. Louis, MO that is committed to providing innovative solutions for the treatment of arrhythmias and the electrophysiology laboratory. Every day, physicians worldwide use this advanced technology to achieve exceptional clinical outcomes without compromising safety, enabling them to confidently treat areas of the heart otherwise unreachable or potentially unsafe with manual techniques or alternative technologies. Stereotaxis’ goal is to make complex cardiac interventions simpler, safer, and more effective. It achieves this with computer controlled, magnetic navigation technology that guides catheters and other devices through the cardiovascular system with great precision and safety. Stereotaxis is the pioneer of magnetic navigation for the electrophysiology lab. Since 2004, clinicians have repeatedly demonstrated the value of this remote magnetic navigation technology for the treatment of cardiac arrhythmias. Additionally, the technology has also been used across a broad range of compelling applications in interventional cardiology. The world’s leading specialists in electrophysiology ablation, cardiac resynchronization therapy and interventional cardiology have all endorsed Stereotaxis’ technologies. Community hospitals, major research institutions and commercial, high-volume healthcare organizations in 30 countries have installed the Stereotaxis’ magnetic navigation system. To date, over 100,000 procedures have been performed worldwide. With a diverse group of clinicians that routinely uses Stereotaxis technology, the company is proud that it is widely recognized for its unrivaled safety profile: 99.9% of procedures performed with the magnetic navigation system have been completed without major complication. Stereotaxis is equally proud that its technologies have limited x-ray exposure for the physician and patient alike, and have allowed physicians to exchange the heavy lead suits required during manual procedures for a comprehensive, user-friendly digital interface through which the procedure can be conducted, from the control room. Stereotaxis provides comprehensive training to the physicians and other healthcare providers who use its products. This dynamic process often inspires the company to develop new devices, software, and procedure solutions to further enhance the practice of interventional medicine. The company designs, manufactures and markets its own products, and works closely with Siemens, Philips and other major global medical device manufacturers to integrate their electrophysiology and cath lab imaging technologies with Stereotaxis systems. In addition, the magnetically-enabled ablation and mapping catheters used with the Stereotaxis remote magnetic navigation system are manufactured and marketed by Biosense Webster, Inc., a Johnson & Johnson company. The appropriate regulatory agencies in the United States, European Union and other countries have cleared and approved the products making the Stereotaxis technology available throughout the world. “I would really like to see the perception change in the EP community around Stereotaxis as it can offer safety and efficacy advantages, especially in VT/PVC patients.” “The benefits of Stereotaxis technology are far greater than conventional methods used to treat arrhythmias, including allowing for more careful analysis of arrhythmia and precise ablation.” “[Stereotaxis] enables extremely safe procedures for all ablations, with huge advantages especially for VT. It also allows me to execute procedures without getting so tired, which could extend my career as an ablation physician.” “With Stereotaxis technology, I’m able to move the catheter easily into every nook and corner of the heart, maintain catheter stability in highly mobile cardiac structures, reduce fluoroscopy time and fatigue, and achieve durable long-term results.” “The Stereotaxis Niobe system is especially beneficial in cardiac venous malformations or for patients after surgery for congenital cardiac disease.” “With the Niobe, we are able to address all types of arrhythmias… This includes not only typical flutters or AV-node-dependent dysrhythmias, but also complex arrhythmias, such as VT and AF.” “[Stereotaxis performs] within difficult to reach parts of the heart and in procedures with baffles and abnormal anatomy.” “[Stereotaxis gives the] ability to reach even the most difficult areas of the heart.” “Stereotaxis is a good teaching tool for understanding the role of electrogram analyses and catheter behavior in cardiac ablation.” Dr. Stephen Ehrlich – Mission Hospital Dr. Aseem Desai – Mission Regional Medical Center “I like Stereotaxis for catheter stability and precise catheter manipulation, as well as the ability to perform flouroless ablations.” “Stereotaxis is a complete change in the technology of EP… we can focus on electrophysiology rather than manual manipulation of the catheter.” “We’ve found distinct advantages with the Niobe system over manual approaches, not only in patient outcomes but in our own productivity. It has made it easier for us to organize and complete heavy daily clinical programs, with less fatigue at the end of the day.” “With Stereotaxis, we are able to reach anywhere in the heart with more precision and safety.” “I’m 100% sold on Stereotaxis technology.” “I believe we provide excellent care for our patients. It makes my practice very rewarding.” “I am most grateful for being able to use the most advanced technologies to help patients.” “Stereotaxis is a great combination of efficacy, safety and maneuverability for all of my complex ablations. I truly feel confident that every arrhythmia can be successfully treated when I use Stereotaxis.” “Stereotaxis provides safety, control and more efficient navigation, and complex cases become very easy with magnetic navigation.” “I’ve always loved the idea of robotics, and Stereotaxis has provided me the ease of navigation in all aspects of the heart, which is impressive.”